NASDAQ: AVXLAnavex Life Sciences Corp Stock Ownership - Who owns Anavex Life Sciences?
Insider buying vs selling
Have Anavex Life Sciences Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christopher U. Missling | President and CEO | 2025-09-11 | 187,500 | $5.04 | $945.00kBuy |
| Christopher U. Missling | President and CEO | 2025-09-11 | 145,048 | $9.58 | $1.39MSell |
| Steffen Thomas | Director | 2025-06-05 | 50,000 | $1.76 | $88.00kBuy |
| Steffen Thomas | Director | 2025-06-05 | 11,349 | $7.75 | $87.95kSell |
| Christopher U. Missling | President and CEO | 2025-03-24 | 500,000 | $0.92 | $460.00kBuy |
| Christopher U. Missling | President and CEO | 2025-03-24 | 282,497 | $9.63 | $2.72MSell |
AVXL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AVXL insiders and whales buy or sell their stock.
AVXL Shareholders
What type of owners hold Anavex Life Sciences Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 8.12% | 7,526,130 | $35.00M | Institution |
| Vanguard Group Inc | 5.43% | 5,028,534 | $23.38M | Institution |
| State Street Corp | 4.73% | 4,383,406 | $20.38M | Institution |
| Geode Capital Management LLC | 2.18% | 2,022,912 | $9.41M | Institution |
| Two Sigma Investments LP | 1.78% | 1,653,696 | $7.69M | Institution |
| Christopher U. Missling | 1.63% | 1,510,165 | $7.02M | Insider |
| Athanasios Skarpelos | 1.41% | 1,306,458 | $6.08M | Insider |
| Two Sigma Advisers LP | 1.31% | 1,209,570 | $5.62M | Institution |
| Summit Financial LLC | 0.97% | 903,392 | $4.20M | Institution |
| George Kalkanis | 0.97% | 900,000 | $4.19M | Insider |
AVXL vs Biotech Stocks
Anavex Life Sciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.